Freeline Therapeutics Holdings plc
DelistedCIK 1810031fmd_0Y4PD4QAPZ5QMC45M01W1F8S7JManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2018 to Sep 30, 2023, 18 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Research and development | 34 | 47 | 76 | 95 | 66 |
| Total operating expenses | 41 | 64 | 102 | 142 | 98 |
| Operating income | (41) | (64) | (102) | (142) | (98) |
| Other non-operating income (expense) | 8 | 10 | 6 | 2 | 10 |
| Income before taxes | (33) | (54) | (96) | (140) | (89) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (33) | (54) | (96) | (140) | (89) |
| Net income | (33) | (54) | (96) | (140) | (89) |